Skip to content

4Accepted Oct 19, 6:30 PM ET

Apple Inc: CFO Kevan Parekh exercised 10,926 shares

AAPLApple Inc.

Accepted (ET)

6:30 PM

Oct 19, 2026

Filed

Oct 19, 2026

Documents

1

Size

20.1 KB

Summary

Apple Inc: CFO Kevan Parekh exercised 10,926 shares

Updated

What happened

  • Kevan Parekh, senior vice president and chief financial officer, exercised or settled 10,926 restricted stock units into 10,926 shares on Oct 15, 2026. The filing shows 5,361 shares were withheld to satisfy tax withholding at $342.00 for $1,833,462. The filing also reports open market sales of 200 shares, 192 shares, 880 shares, 80 shares and 40 shares on Oct 16, 2026, for aggregate proceeds of $480,316. Two additional derivative-disposition entries on Oct 15, 2026 show 5,816 shares and 5,110 shares disposed (reported as derivative transactions).

Key details

  • Transaction dates and prices: Oct 15, 2026 (settlement/exercise); Oct 16, 2026 (open market sales) at weighted-average prices reported in the filing: $342.66, $343.68, $345.66, $346.47 and $347.46; the filing notes trade price ranges from $342.25 to $347.46 across the sales.
  • Shares withheld/tax: 5,361 shares withheld at $342.00 for $1,833,462 (tax withholding on vesting).
  • Shares sold: 1,392 shares sold in open market transactions on Oct 16, 2026 for $480,316 (weighted-average and multiple-trade disclosures included).
  • Award and vesting notes: the filing identifies awards granted Sep 25, 2022 and Oct 1, 2023 with semi-annual vesting through Oct 15, 2026 and Oct 15, 2027, respectively.
  • 10b5-1 plan: the filing states the Oct 16, 2026 open market sales were made pursuant to a Rule 10b5-1 trading plan adopted Nov 21, 2025.
  • Shares owned after the transactions: the filing does not state the number of shares owned after the transactions.
  • Timeliness: the form was filed Oct 19, 2026; the filing does not indicate it was late.

Why it may matter

  • The filing shows vesting/settlement of restricted stock units with shares withheld to cover taxes (a net settlement) and separate open-market sales executed under a Rule 10b5-1 plan.
  • For derivative entries, the filing reports exercises/conversions and related dispositions rather than a simple market purchase.
  • A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing